Antihypertensive and vasoprotective effects of epigallocatechin-3-gallate(EGCG) in spontaneously hypertensive rats

Epigallocatechin-3-gallate (EGCG), a catechin found in green tea is demonstrated to exert blood pressure-lowering effect in hypertensive subjects with elevated oxidative stress. However, the exact underlying mechanism remains unknown. The current study investigated whether the decrease in ROS prod...

Full description

Bibliographic Details
Main Author: Khor, Yucinda Yee Yan
Format: Final Year Project / Dissertation / Thesis
Published: 2024
Subjects:
Online Access:http://eprints.utar.edu.my/6409/
http://eprints.utar.edu.my/6409/1/DIR_2004378.pdf
_version_ 1848886671194456064
author Khor, Yucinda Yee Yan
author_facet Khor, Yucinda Yee Yan
author_sort Khor, Yucinda Yee Yan
building UTAR Institutional Repository
collection Online Access
description Epigallocatechin-3-gallate (EGCG), a catechin found in green tea is demonstrated to exert blood pressure-lowering effect in hypertensive subjects with elevated oxidative stress. However, the exact underlying mechanism remains unknown. The current study investigated whether the decrease in ROS production via the modulation of angiotensin type I receptor (AT1) contributes to the vasoprotective action of EGCG observed in an animal model with primary hypertension. Wistar-Kyoto (WKY) rats and Spontaneously Hypertensive Rats (SHR) were grouped into WKY Control, SHR Control, SHR treated with EGCG (50mg/kg/day) and SHR treated with losartan (10mg/kg/day) respectively. The treatment was given daily for 4 weeks by oral gavage and the blood pressure was monitored by tail-cuff method every 3 days. Acetylcholine-induced vascular relaxation was assessed in isolated aortic rings contracted with phenylephrine at the end of treatment. The vascular levels of nitric oxide (NO), reactive oxygen species (ROS), tetrahydrobiopterin (BH4) and cyclic guanosine monophosphate (cGMP) were also measured. Lastly, expression of AT1 receptor protein was analysed. After 4 weeks of treatment, the was a significant decrease in systolic blood pressure of the SHR treated with EGCG and losartan. In line with this, there was significant improvement in endothelium-dependent relaxation in aortic ring isolated from EGCG and losartan-treated SHR groups. The ROS level was also decreased in these groups. Besides that, the levels of NO, BH4 and cGMP were also significantly increased in SHR treated with EGCG or losartan. It was also observed that there was a decreasing trend in the protein expression of AT1 receptor in SHR treated with EGCG and losartan. In conclusion, this study shows that EGCG improves endothelial function in SHR by attenuating oxidative stress and elevating the bioavailability of vascular NO, which may be modulated partly by downregulation of vascular AT1 receptors. The increase in endothelium-dependent relaxation in part may have contributed to the blood pressure lowering effect of EGCG in the hypertensive animals.
first_indexed 2025-11-15T19:42:12Z
format Final Year Project / Dissertation / Thesis
id utar-6409
institution Universiti Tunku Abdul Rahman
institution_category Local University
last_indexed 2025-11-15T19:42:12Z
publishDate 2024
recordtype eprints
repository_type Digital Repository
spelling utar-64092024-06-19T01:21:28Z Antihypertensive and vasoprotective effects of epigallocatechin-3-gallate(EGCG) in spontaneously hypertensive rats Khor, Yucinda Yee Yan R Medicine (General) RS Pharmacy and materia medica Epigallocatechin-3-gallate (EGCG), a catechin found in green tea is demonstrated to exert blood pressure-lowering effect in hypertensive subjects with elevated oxidative stress. However, the exact underlying mechanism remains unknown. The current study investigated whether the decrease in ROS production via the modulation of angiotensin type I receptor (AT1) contributes to the vasoprotective action of EGCG observed in an animal model with primary hypertension. Wistar-Kyoto (WKY) rats and Spontaneously Hypertensive Rats (SHR) were grouped into WKY Control, SHR Control, SHR treated with EGCG (50mg/kg/day) and SHR treated with losartan (10mg/kg/day) respectively. The treatment was given daily for 4 weeks by oral gavage and the blood pressure was monitored by tail-cuff method every 3 days. Acetylcholine-induced vascular relaxation was assessed in isolated aortic rings contracted with phenylephrine at the end of treatment. The vascular levels of nitric oxide (NO), reactive oxygen species (ROS), tetrahydrobiopterin (BH4) and cyclic guanosine monophosphate (cGMP) were also measured. Lastly, expression of AT1 receptor protein was analysed. After 4 weeks of treatment, the was a significant decrease in systolic blood pressure of the SHR treated with EGCG and losartan. In line with this, there was significant improvement in endothelium-dependent relaxation in aortic ring isolated from EGCG and losartan-treated SHR groups. The ROS level was also decreased in these groups. Besides that, the levels of NO, BH4 and cGMP were also significantly increased in SHR treated with EGCG or losartan. It was also observed that there was a decreasing trend in the protein expression of AT1 receptor in SHR treated with EGCG and losartan. In conclusion, this study shows that EGCG improves endothelial function in SHR by attenuating oxidative stress and elevating the bioavailability of vascular NO, which may be modulated partly by downregulation of vascular AT1 receptors. The increase in endothelium-dependent relaxation in part may have contributed to the blood pressure lowering effect of EGCG in the hypertensive animals. 2024 Final Year Project / Dissertation / Thesis NonPeerReviewed application/pdf http://eprints.utar.edu.my/6409/1/DIR_2004378.pdf Khor, Yucinda Yee Yan (2024) Antihypertensive and vasoprotective effects of epigallocatechin-3-gallate(EGCG) in spontaneously hypertensive rats. Master dissertation/thesis, UTAR. http://eprints.utar.edu.my/6409/
spellingShingle R Medicine (General)
RS Pharmacy and materia medica
Khor, Yucinda Yee Yan
Antihypertensive and vasoprotective effects of epigallocatechin-3-gallate(EGCG) in spontaneously hypertensive rats
title Antihypertensive and vasoprotective effects of epigallocatechin-3-gallate(EGCG) in spontaneously hypertensive rats
title_full Antihypertensive and vasoprotective effects of epigallocatechin-3-gallate(EGCG) in spontaneously hypertensive rats
title_fullStr Antihypertensive and vasoprotective effects of epigallocatechin-3-gallate(EGCG) in spontaneously hypertensive rats
title_full_unstemmed Antihypertensive and vasoprotective effects of epigallocatechin-3-gallate(EGCG) in spontaneously hypertensive rats
title_short Antihypertensive and vasoprotective effects of epigallocatechin-3-gallate(EGCG) in spontaneously hypertensive rats
title_sort antihypertensive and vasoprotective effects of epigallocatechin-3-gallate(egcg) in spontaneously hypertensive rats
topic R Medicine (General)
RS Pharmacy and materia medica
url http://eprints.utar.edu.my/6409/
http://eprints.utar.edu.my/6409/1/DIR_2004378.pdf